MORETTI, SILVIA
 Distribuzione geografica
Continente #
NA - Nord America 15.835
EU - Europa 12.259
AS - Asia 6.237
SA - Sud America 720
AF - Africa 245
OC - Oceania 173
Continente sconosciuto - Info sul continente non disponibili 115
Totale 35.584
Nazione #
US - Stati Uniti d'America 15.611
PL - Polonia 3.423
RU - Federazione Russa 3.311
IT - Italia 1.980
SG - Singapore 1.758
CN - Cina 1.142
HK - Hong Kong 1.046
IE - Irlanda 902
SE - Svezia 847
VN - Vietnam 720
KR - Corea 606
BR - Brasile 551
DE - Germania 385
FI - Finlandia 367
FR - Francia 357
UA - Ucraina 300
IN - India 278
GB - Regno Unito 217
AU - Australia 169
TR - Turchia 156
CA - Canada 139
JO - Giordania 96
CI - Costa d'Avorio 95
JP - Giappone 74
BD - Bangladesh 63
AR - Argentina 60
ID - Indonesia 54
IQ - Iraq 50
ES - Italia 40
MX - Messico 37
NL - Olanda 32
EC - Ecuador 29
NG - Nigeria 26
EG - Egitto 23
PH - Filippine 23
VE - Venezuela 23
PK - Pakistan 22
CO - Colombia 21
ZA - Sudafrica 21
SA - Arabia Saudita 18
AE - Emirati Arabi Uniti 17
CH - Svizzera 17
TH - Thailandia 17
KE - Kenya 15
MA - Marocco 15
SC - Seychelles 15
UZ - Uzbekistan 14
RO - Romania 13
CL - Cile 10
EU - Europa 10
PY - Paraguay 10
BE - Belgio 9
IR - Iran 9
JM - Giamaica 9
NP - Nepal 9
BG - Bulgaria 8
IL - Israele 8
MY - Malesia 8
AZ - Azerbaigian 7
PE - Perù 7
DK - Danimarca 6
DZ - Algeria 6
OM - Oman 6
SN - Senegal 6
BA - Bosnia-Erzegovina 5
CZ - Repubblica Ceca 5
GT - Guatemala 5
HU - Ungheria 5
KW - Kuwait 5
KZ - Kazakistan 5
SV - El Salvador 5
UY - Uruguay 5
AT - Austria 4
BB - Barbados 4
BO - Bolivia 4
ET - Etiopia 4
GE - Georgia 4
LB - Libano 4
LT - Lituania 4
TN - Tunisia 4
TT - Trinidad e Tobago 4
TW - Taiwan 4
AL - Albania 3
BJ - Benin 3
BY - Bielorussia 3
CR - Costa Rica 3
DO - Repubblica Dominicana 3
HR - Croazia 3
KG - Kirghizistan 3
NZ - Nuova Zelanda 3
PA - Panama 3
PR - Porto Rico 3
PT - Portogallo 3
AO - Angola 2
BF - Burkina Faso 2
CM - Camerun 2
GR - Grecia 2
HN - Honduras 2
MD - Moldavia 2
MK - Macedonia 2
Totale 35.450
Città #
Warsaw 3.417
Santa Clara 2.944
Fairfield 1.284
Singapore 1.159
Ashburn 1.156
Chandler 957
Dublin 902
San Jose 868
Hong Kong 796
Seoul 602
Cambridge 540
Woodbridge 518
Jacksonville 498
Seattle 483
Houston 459
Milan 458
Wilmington 444
Council Bluffs 373
Beijing 313
The Dalles 293
Princeton 283
Buffalo 235
Lauterbourg 230
Boston 228
Rome 213
Mumbai 211
Ho Chi Minh City 207
Ann Arbor 199
Los Angeles 197
Melbourne 165
Hanoi 159
Boardman 152
Phoenix 146
Izmir 135
Florence 122
Hefei 121
Moscow 106
Altamura 96
Abidjan 95
Dallas 94
New York 94
Medford 93
Lawrence 91
San Diego 90
Munich 79
Helsinki 75
Paris 69
Tokyo 67
Naples 61
Shanghai 60
Norwalk 49
Toronto 42
Figino 41
Frankfurt am Main 38
Dong Ket 36
Jakarta 36
Bologna 35
Da Nang 35
Turin 35
Washington 35
Haiphong 34
Andover 33
São Paulo 31
Hillsboro 30
Chicago 29
Turku 29
Redondo Beach 27
Abuja 25
Barcelona 24
Bremen 24
Guangzhou 24
Rio de Janeiro 24
Baghdad 23
Clifton 23
Falls Church 23
Brescia 22
Venice 22
Kent 21
Orem 21
Brooklyn 20
Montreal 20
Palermo 20
Bari 19
Catania 19
Frankfurt Am Main 19
London 19
Tianjin 18
Verona 18
Biên Hòa 17
Denver 17
Genoa 17
Modena 17
Atlanta 15
Quito 14
Amsterdam 13
Campinas 13
Chennai 13
Cagliari 12
Miami 12
San Francisco 12
Totale 23.852
Nome #
B-cell lymphoma with secondary cutaneous involvement: an immunohistochemical and ultrastructural study 399
Nonconventional Use of Flash-Lamp Pulsed-Dye Laser in Dermatology 344
Tattoo-Associated Skin Reaction: The Importance of an Early Diagnosis and Proper Treatment 338
Efficacy of Rhodamine Light in the Treatment of Superficial Vascular Lesions of the Face 335
Hair and Scalp Disorders in a Tuscan Pediatric Dermatological Outpatient Clinic: A Clinical and Epidemiological Evaluation 331
STEM CELL FACTOR AFFECTS TUMOUR PROGRESSION MARKERS IN METASTATIC MELANOMA CEELS 317
LANGERHANS CELLS AND MYCOSIS FUNGOIDES-A CRITICAL OVERVIEW OF THEIR PATHOGENIC ROLE IN THE DISEASE 314
Antigenic phenotype of radial growth phase melanomas with or without a vertical growth phase portion. 313
Primary cutaneous follicular centre- cell lymphoma- a lymphoproliferative disease with favourable prognosis. 311
A peculiar case of linear IgA bullous dermatosis. 304
Adult Onset Vitiligo: Multivariate Analysis Suggests the Need for a Thyroid Screening. 302
No Association between Vitiligo and Obesity: A Case-Control Study. 295
Classic and immunodeficiency-associated Kaposi's sarcoma. Clinical, histologic and immunologic correlations. 292
Potential Infectious Etiology of Behçet's Disease 292
Plaque-type parapsoriasis and mycosis fungoides: An unclear relationship 283
Stress as a possible mechanism in melanoma progression 281
Can environmental factors contribute in triggering vitiligo and associated autoimmune thyroid diseases? Clinical series possibly related to the Chernobyl nuclear accident. 281
Non-lymphoid accessory cells in the cutaneous infiltrate of B cell lymphomas. An immunohistochemical and ultrastructural study 276
Interdigitating reticulum cells in the dermal infiltrate of mycosis fungoides. An ultrastructural and immunohistochemical study. 274
Norepinephrine promotes tumor microenvironment reactivity through β3-adrenoreceptors during melanoma progression. 273
Multiple marker studies on a malignant fibrous hystiocytoma with primary cutaneous localization. 271
Oxidative Stress and Immune System in Vitiligo and Thyroid Diseases. 271
Conventional and unconventional use of lasers in skin disorders 266
Treatment of recurrent pilonidal cysts with nd-YAG laser: report of our experience 258
Cellule di Sézary: attività immunologiche " in vitro" ed effetto della timostimulina 246
Interessamento cutaneo in corso di leucemia mielo-monocitica 242
Successful treatment of acne keloidalis nuchae resistant to conventional therapy with 1064-nm ND:YAG laser 242
Highlights of thirty years experience of CO2 laser use at the Florence (Italy) Department of Dermatology 231
Increased oxidative DNA damage in mononuclear leukocytes in vitiligo 223
Lichen planus and liver diseases: a multicentre case- control study. 219
A 2-Month-Old Boy with Desquamative Skin Fold Dermatitis 215
Thyroid disorders in vitiligo patients. 214
Genome-wide association studies of autoimmune vitiligo identify 23 new risk loci and highlight key pathways and regulatory variants 212
Multiple clustered nodules on the leg. 211
A case of chronic herpes gestationis: persistent disease or conversion to bullous pemphigoid? 207
The role of the detection of hematogenous micrometastasis in prostate adenocarcinoma and malignant melanoma by RT-PCR. 202
Treatment with low-dose cytokines reduces oxidative-mediated injury in perilesional keratinocytes from vitiligo skin 202
Oral carcinoma in a young man: a case of dyskeratosis congenita. 202
Are Langerhans cells usual components of the dermal infiltrate of mycosis fungoides? 199
Autoimmune markers in vitiligo patients appear correlated with obsession and phobia 191
Evidence of a possible therapeutic role of vitamin D in a cohort of adult Caucasian vitiligo patients 190
Correlation of Serum Thyroid Hormones Autoantibodies with Self-Reported Exposure to Thyroid Disruptors in a Group of Nonsegmental Vitiligo Patients. 184
Autoimmune signals in non-segmental vitiligo patients are associated with distinct clinical parameters and toxic exposures. 181
If herpes does not heal … change strategy! 180
Arachidonate transforming and immunomodulating agents; unapproved usual indications. 180
Protease-activated receptor-2 downregulation is associated to vitiligo lesions 180
Drug consumption and melanocytic nevi: correlation between oral contraceptives or hormone replacement therapy and a high melanocytic nevi count 178
Molecular detection of microsatellite instability in basal cell carcinoma. 176
Polycystic ovary syndrome and vitiligo: simple association or tight connection? 173
A case of angiosarcoma of the face successfully treated with combined chemotherapy and radiotherapy. 172
ROS-challenged keratinocytes as a new model for oxidative stress-mediated skin diseases 172
Evaluation of an oral supplement containing Phyllanthus emblica fruit extracts, vitamin E and carotenoids in vitiligo treatment 170
Immunohistochemical evidence of cytokine networks during progression of human melanocytic lesions. 169
Mast cells do not play a role in vitiligo 168
Non-segmental vitiligo and psoriasis comorbidity - a case-control study in Italian patients 168
Vitiligo: new and emerging treatments. 167
Lesioni pigmentate vulvari 167
A case of photoallergic contact dermatitis caused by unusual exposure to ketoprofen 167
Vitiligo and epidermal microenvironment: possible involvement of keratinocyte-derived cytokines. 166
Seasonal variations of DNA damage in human lymphocytes: correlation with different environmental variables 166
Autoimmune markers in vitiligo patients appear correlated with obsession and phobia 166
Cutaneous sarcoid-like granulomas in a patient with x-linked hyper-IgM syndrome 165
A multiparametric approach is essential to define different clinicopathological entities within pseudopelade of Brocq: replay from authors 165
The definition and assessment of vitiligo: a consensus report of the Vitiligo European Task Force 163
Autoimmune polyglandular type IIIc syndrome associated with Vogt-Koyanagi-Harada syndrome and common variable immunodeficiency 163
Dendritic cells in the dermal infiltrate of Sézary syndrome 163
Commentary from the Editorial Board to Vitiligo: interplay between oxidative stress and immune system (Laddha et al.). 163
Pseudoepitheliomatous hyperplasia in a tattoo 162
Validation of a physician global assessment tool for vitiligo extent: Results of an international vitiligo expert meeting 157
Sequential effects of photodynamic treatment of basal cell carcinoma 156
Fibrogenic cytokines in vulvar lichen sclerosus. An immunohistochemical study. 154
The role of stress and beta-adrenergic system in melanoma: current knowledge and possible therapeutic options 153
Bacterial skin and soft tissue infections: review of the epidemiology, microbiology, aetiopathogenesis and treatment: A collaboration between dermatologists and infectivologists 153
Early diagnosis for melanoma: is open access to skin cancer clinics really significant? A prospective study. 153
The prognostic significance of histologic regression in cutaneous melanoma. 152
Pediatric pigmented Spitz nevus: A natural course toward involution assessed with dermoscopy 152
Autoimmune thyroid disease in Italian patients with non-segmental vitiligo 151
Adhesion molecules expression and melanoma progression 150
Keratinocyte dysfunction in vitiligo epidermis: cytokine microenvironment and correlation to keratinocyte apoptosis 149
Primary cutaneous follicular center cell lymphoma: clinical and histological aspects. 148
Accessory cells in lichen planus and mycosis fungoides: a comparative study 147
In situ immunologic characterization of cutaneous involvement in Hodgkin's disease. 147
Dermatosis Papulosa Nigra and 10,600-nm CO2 laser, a good choice. 146
Inflammatory linear verrucous epidermal nevus: why a combined laser therapy 145
High prevalence of circulating autoantibodies against thyroid hormones in vitiligo and correlation with clinical and historical parameters of patients 145
Cell surface marker studies in a patient with cutaneous multilobated T-cell lymphoma. 144
Adhesion molecule expression in human melanocytic lesions 143
Progression of mycosis fungoides is associated with changes in angiogenesis and expression of the matrix metalloproteinases 2 and 9. 143
Milia-like idiopathic calcinosis cutis in the absence of Down's syndrome. 142
A case of circinnate sarcoidosis of the face 141
Efficacy and safety evaluation of an innovative CO2 laser/radiofrequency device in dermatology 140
Ki-67 antigen expression correlates with tumor progression and HLA-DR antigen expression in melanocytic lesions. 138
Angiogenesis of cutaneous melanoma 138
Ocular "non scarring" mucous membrane pemphigoid associated with anti-laminin 5 antibodies 138
Persistent herpes gestationis 137
Koebner's phenomenon in vitiligo: European position paper 137
Apoptosis in non-segmental vitiligo 137
Involvement of PAR-2 in vitiligo 137
A case of late onset prurigo of pregnancy 137
Fibrogenic cytokines in cutaneous-mucosal inflammatory models. 136
Totale 20.109
Categoria #
all - tutte 93.461
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 93.461


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.220 0 0 44 65 48 59 37 80 63 64 218 542
2022/20233.631 455 304 140 294 365 758 486 222 416 14 133 44
2023/20241.242 62 186 308 82 99 211 42 143 8 23 43 35
2024/20258.744 304 1.035 738 1.272 2.656 1.009 93 443 496 245 276 177
2025/20269.056 969 1.311 592 462 853 344 1.331 369 623 532 190 1.480
2026/20271.494 283 348 863 0 0 0 0 0 0 0 0 0
Totale 35.584